Biotech

All Articles

Aligos declares period 2 MASH win, slashing liver excess fat around 46%

.Aligos Therapies is advertising a midstage gain in metabolic-dysfunction affiliated steatohepatitis...

Basilea scores $268M BARDA backing for antifungals, prescription antibiotics

.Basilea Pharmaceutica's job developing brand-new antifungals has acquired a substantial increase co...

Capricor offers Europe legal rights to late-stage DMD therapy for $35M

.Having currently gathered up the USA liberties to Capricor Rehabs' late-stage Duchenne muscle dystr...

FDA junks adcomm for Applied's uncommon condition medication

.After dismissing the choice meeting for Applied Therapies' metabolic disorder drug govorestat, the ...

Novo inks $600M NanoVation bargain to analyze hereditary medicines ex-liver

.Novo Nordisk is continuing its press into hereditary medications, agreeing to compensate NanoVation...

Innovent links cytokine to colorectal cancer reactions

.Innovent Biologics has actually helped make the situation that its checkpoint inhibitor-cytokine co...

Merck, Daiichi ADC attacks target in phase 3 lung cancer study

.A stage 3 test of Daiichi Sankyo and also Merck &amp Co.'s HER3-directed antibody-drug conjugate (A...

Rakovina strengthens AI focus along with collab to select cancer cells intendeds

.5 months after Rakovina Therapies pivoted towards expert system, the cancer-focused biotech has sig...

Ascendis' dwarfism medicine favorites in stage 3, threatens BioMarin

.Ascendis Pharma has become a possible risk to BioMarin's Voxzogo, mentioning phase 3 growth problem...

Despite ph. 3 miss out on, Alkeus views path in advance for eye disease asset

.Though Alkeus Pharmaceuticals' dental eye disease property stopped working to substantially lessen ...